Innovation in the production process of veterinary drugs against leptospirosis and borreliosis (Q9935): Difference between revisions
Jump to navigation
Jump to search
(Changed an Item: Label in wikidata changed) |
(Changed an Item: Label in wikidata changed) |
||
| label / en | label / en | ||
Innovation in the production process of veterinary | Innovation in the production process of veterinary drugs against leptospirosis and borreliosis | ||
Revision as of 18:59, 17 February 2020
Project in Czech Republic financed by DG Regio
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Innovation in the production process of veterinary drugs against leptospirosis and borreliosis |
Project in Czech Republic financed by DG Regio |
Statements
7,500,000.0 Czech koruna
0 references
30,000,000.0 Czech koruna
0 references
25 percent
0 references
19 November 2015
0 references
23 August 2018
0 references
1 October 2018
0 references
Bioveta, a.s.
0 references
49°18'9.65"N, 17°4'54.52"E
0 references
49°17'53.88"N, 17°6'21.31"E
0 references
68323
0 references
Předmětem projektu je inovace procesu výroby a kultivace vakcín proti leptospiróze a borelióze založená na pomnožení spirochet fermentační kultivací v průmyslovém bioreaktoru. Inovace procesu bude realizována formou zavedení nové technologie výroby antigenů. Inovace se týká celé řady přípravků (např. Biocan L, Biocan Novel L4, B BioBos L, BioBos L6, Biofel B, Biocan B, Borrelym). V rámci projektu bude pořízena technologie pro nový způsob výroby, a to bioreaktory, formulační kotel a ultrafiltr. a. (Czech)
0 references
Identifiers
CZ.01.1.02/0.0/0.0/15_014/0004382
0 references